Michael Golembiewski - Jan 10, 2022 Form 4 Insider Report for SEELOS THERAPEUTICS, INC. (SEEL)

Role
Chief Financial Officer
Signature
/s/ Michael Golembiewski
Stock symbol
SEEL
Transactions as of
Jan 10, 2022
Transactions value $
$0
Form type
4
Date filed
1/11/2022, 03:27 PM
Previous filing
Sep 2, 2021
Next filing
Mar 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SEEL Stock Option (right to buy) Award $0 +500K $0.00 500K Jan 10, 2022 Common Stock 500K $1.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on January 10, 2023, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.